Primary study · included by 1 review
Systemic treatment with resveratrol and/or curcumin reduces the progression of experimental periodontitis in rats.
Correa 2017 · Corrêa M G, Pires P R, Ribeiro F V, et al. · Journal of periodontal research · 2017
Included by
| Outcome this study informs | Pooled effect | Evidence | Certainty |
|---|---|---|---|
IL-1β protein expression in gingiva Resveratrol vs Periodontitis model without resveratrol (placebo or untreated) | SMD -0.87 [-1.49, -0.25] | 2 studies · 44 participants | GRADE not reported |
Alveolar bone crest level (CEJ to bone crest distance, mm) Resveratrol vs Periodontitis model without resveratrol (placebo or untreated) | MD -0.10 [-0.12, -0.08] | 3 studies | GRADE not reported |
Alveolar bone crest level (CEJ to bone crest distance, mm) Resveratrol vs Periodontitis model without resveratrol (placebo or untreated) | MD -0.10 [-0.12, -0.08] | 3 studies | GRADE not reported |
Alveolar bone crest level (CEJ to bone crest distance, mm) Resveratrol vs Periodontitis model without resveratrol (placebo or untreated) | MD -0.10 [-0.14, -0.06] | 3 studies | GRADE not reported |
Alveolar bone crest level (CEJ to bone crest distance, mm) Resveratrol vs Periodontitis model without resveratrol (placebo or untreated) | MD -0.10 [-0.11, -0.08] | 4 studies · 62 participants | GRADE not reported |
Alveolar bone crest level (CEJ to bone crest distance, mm) Resveratrol vs Periodontitis model without resveratrol (placebo or untreated) | MD -0.10 [-0.12, -0.08] | 4 studies | GRADE not reported |
Alveolar bone crest level (CEJ to bone crest distance, mm) Resveratrol vs Periodontitis model without resveratrol (placebo or untreated) | MD -0.10 [-0.12, -0.08] | 3 studies | GRADE not reported |
1 including review in total.